B of A Securities Maintains Neutral on Pfizer, Lowers Price Target to $26

Benzinga Newsdesk www.benzinga.com Negative 70.0%

Neg 70% Neu 0% Pos 0%

B of A Securities analyst Jason Gerberry maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $27 to $26.